14:19:07 EDT Sat 22 Jun 2024
Enter Symbol
or Name

Login ID:
Lifeist Wellness Inc
Symbol LFST
Shares Issued 594,087,243
Close 2024-05-08 C$ 0.005
Market Cap C$ 2,970,436
Recent Sedar Documents

Lifeist's Mikra, Virun partner, roll out CELLF 2.0

2024-05-09 11:29 ET - News Release

Mr. Meni Morim reports


Lifeist Wellness Inc.'s United States biosciences subsidiary Mikra Cellular Sciences Inc. has partnered with Virun NutraBiosciences Inc., the global leader in NutraBiosciences, to offer CELLF 2.0, an enhanced nutraceutical gel for improving cellular health. CELLF 2.0 is available for sale now and can be ordered directly at the Mikra website.

"We are so excited to partner exclusively with Mikra and their CELLF brand containing glutathione, PQQ and CoQ10. Our patents and patents-pending technologies are a perfect fit for Mikra. The anti-aging, mitochondrial biogenesis benefits of CELLF 2.0 are unrivalled," said Philip Bromley, chief executive officer of Virun NutraBiosciences.

"We are delighted to partner with Virun to leverage their industry-leading scientific expertise, stellar manufacturing facilities and patented, next-generation liposomal delivery platform to bring you the new and improved CELLF 2.0," said Meni Morim, CEO of Lifeist. "Featuring an enhanced flavour profile and smoother consistency, thanks to Virun's patented liposomal delivery technology, CELLF 2.0 arrives in a more environmentally friendly recyclable package and convenient individual sachet form factor. This new manufacturing partnership has enabled Mikra to improve on an already great product and also allows us to offer an annual subscription option of CELLF 2.0 at a 46-per-cent discount, while still maintaining strong margins. CELLF 2.0 is available for sale today at wearemikra.com."

CELLF 2.0 provides a complete adult daily dose of pyrroloquinoline quinone (PQQ) and glutathione, alongside the recommended dose of bioavailable CoQ10, in a liposomal gel that is precision engineered to protect all of these key molecules from the corrosive effects of stomach acid, delivering them safely to be absorbed by the small intestine and guaranteeing that the full clinical dose becomes bioavailable. The latest published research confirms the vital role played by CELLF 2.0's key ingredients.

In 2023, a double-blind, randomized controlled trial completed in Japan found:

  • After 12 weeks, the participants showed improvements in composite memory and verbal memory ... In younger adults (aged 20 to 40 years), PQQ improved cognitive function (cognitive flexibility, processing speed and execution speed) after eight weeks ... Older adults (aged 41 to 65 years) showed improvements in complex and verbal memory after 12 weeks.

In 2023, a study conducted jointly at Canadian and Chinese research universities concluded:

  • This study reveals the underlying mechanism of PQQ's strong antioxidant capacity, and provides evidence for PQQ as a potential agent for clinical prevention and treatment of natural aging-induced osteoporosis.

In 2023, a comprehensive research review completed at a medical university in Italy determined:

  • There is evidence of enhanced glutathione levels in elderly subjects with excellent physical and mental health status, suggesting that heightened glutathione may be a marker, and even a causative factor, of increased healthspan and lifespan. Such aspects, and much more, including glutathione-boosting substances administrable to humans, are considered in this state-of-the-art review, which deals with glutathione and glutathione-dependent enzymes from biochemistry to gerontology, focusing attention also on lifespan/healthspan extension and successful aging; the significance of glutathione levels in aging is considered also in relation to therapeutic possibilities and supplementation strategies ... Aimed at increasing glutathione and related defenses to improve health status and counteract aging processes in humans.

CELLF 2.0 is a clinically validated formula proven to boost energy and focus on a cellular level, while protecting against the negative effects of oxidative stress. Meticulously researched, the precision-engineered formula is designed to add healthy, energetic years to your life, so you can feel better, longer. Lifeist is committed to bringing natural products backed by real science to market and looks forward to reaching many more customers in 2024.

About Virun NutraBiosciences Inc.

Founded in 2003, Virun NutraBioSciences was formed to create nutritious, great tasting and novel formulations for the food, beverage, supplement and pharmaceutical industries.

Since its inception Virun has developed over 50 product concentrates, over 100 commercialized products that allow difficult-to-dissolve, fortifiable ingredients into food and beverage applications that are associated with efficacious health claims, and has worked with over 100 clients spanning across several industries. Virun not only creates medical-grade pharmaceutical supplements, but also expanded into the foods and beverages market.

Seeing an important correlation between drug delivery and nutrient delivery, Mr. Bromley, chief executive officer, was able to apply the principles of biology and chemistry to functional foods, beverages and supplements. As a result, Virun NutraBiosciences now holds more than 100 patents and patents pending worldwide, and is the only company capable of creating truly functional and innovative formulations and products for clients in the food, beverage, health and wellness, and pharmaceutical industries.

Virun specializes in oil emulsions for ingredients such as Omega-3 EPA (eicosapentaenoic acid)/DHA (docosahexaenoic acid), astaxanthin and PQQ, but is able to deliver probiotics through an advanced technique that increases probiotic survivability and high shelf-life. The company continues to invest in and create technologies that change the way people receive nutritious ingredients.

About Lifeist Wellness Inc.

Sitting at the forefront of the postpandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: Mikra, a biosciences and consumer wellness company developing and selling innovative products for cellular health; CannMart, which operates a B2B (business-to-business) wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards, including for CannMart Labs, a BHO (butane hash oil) extraction facility producing high-margin cannabis 2.0 products; and Australian Vapes, one of Australia's largest on-line retailers of vaporizers and accessories.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.